No differences were observed in the frequency of CD19+ B cells, CD3+CD8+ and CD3+CD4+ T cells, CD16+56+ NK cells, and CD4+CD25+Foxp3+ T regulatory cells in peripheral blood of T2D patients compared with controls (Figure 1). Here, CD19 is linked to type 2 diabetes mellitus.